Mefloquine is one of four antimalarial agents commonly recommended for preventing malaria in travellers to malaria-endemic areas. Despite its high efficacy, there is controversy about its psychological side effects. In this short video, Cochrane author Dr Maya Tickell-Painter, talks about the effectiveness and side effects of mefloquine following the publication of two reviews:
Cochrane and WHO meet in Geneva, April 2017
27 June 2017
Evidence for population health improvement: can genomics help?
Liverpool School of Tropical Medicine, Seminar Series: 15 March 2017
Medical Journals and the Medicalization of Global Health
Liverpool School of Tropical Medicine, Seminar Series: 15 February 2017
Systematic reviews of diagnostic test accuracy in infectious diseases
Liverpool School of Tropical Medicine, Seminar Series: 24 November 2016
Uses and limits of research evidence in shaping global HIV policy and practice
Liverpool School of Tropical Medicine, Seminar Series: 3 February 2016
Leverhulme Lecture 2015: Ecstasies and agonies of evidence synthesis
Liverpool School of Tropical Medicine (LSTM); 17 November 2015
How to make a case for deworming
2014 Cochrane Colloquium
Cochrane Profile: Prathap Tharyan
Systematic reviews and international development by Professor Paul Garner
Twenty years of The Cochrane Collaboration:
Malaria research: making an impact in Nigeria
Martin Meremikwu, Professor of Paediatrics and Child Health, University of Calabar, Nigeria talks about his work on a Cochrane Systematic Review about giving drugs to help prevent malaria illness in young children living in malaria areas. He also describes how evidence-based research is influencing policy in Nigeria, and how the local media around Calabar are also recognising the importance of an evidence-base to inform the health care stories that they cover. He considers how the young staff at the University of Calabar are demanding high quality evidence-based research, partly as a result of their involvement in The Cochrane Collaboration. Professor Meremikwu is interviewed by Paul Garner, Director of the EHCRC and Co-ordinating Editor of the CIDG.
Malaria research: making an impact in Uganda
Hasifa Bukirwa from Uganda, talks here about her work on Cochrane reviews in malaria treatment and how she then went on to run clinical trials in this area. Hasifa is now a Medical Epidemiologist, Centres for Diseases Control and Prevention. Her review of ‘LapDap’ (chlorproguanil-dapsone) helped clarify some of the adverse effects outlined in the early trials, and was used by the WHO in decisions about next steps with this drug.
Global malaria policy: the impact of research synthesis
How accurate are rapid diagnostic tests in malaria? Piero Olliaro, Leader for Research on Neglected Tropical Diseases at the World Health Organization/Special Programme for Research and Training in Tropical Diseases (WHO/TDR) talks about how a Cochrane Systematic Review published in 2011 fits into the landscape of global malaria policy, and describes how evidence has influenced WHO malaria treatment recommendations for malaria treatment over the last 15 years. Dr. Olliaro talks to Paul Garner, Director of the EHCRC and Co-ordinating Editor of the CIDG.
Saving lives: global expert on research and research synthesis in community child health
Zulfiqar A. Bhutta, Chair of the Department of Paediatrics and Child Health at Aga Khan University in Pakistan, talks about community child health evidence-based approaches in developing countries, and gives advice to aspiring health professionals interested in this area. Professor Bhutta is involved with 45 Cochrane Reviews, is internationally recognised as a leader in his field, and heads a research team.